Glaxosmithkline reported 5.72B in Operating Expenses for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Amgen AMGN:US $ 3.77B 854M
Aphria Inc APH:CN C$ 221.95M 18.21M
AstraZeneca AZN:LN 5.43B 498M
Bristol Myers Squibb BMY:US $ 9.32B 13.58B
Canopy Growth Corp WEED:CN C$ 381.01M 325.13M
Catalent CTLT:US $ 701.9M 82.3M
Corcept Therapeutics CORT:US $ 59.8M 4.57M
Drreddys Laboratories RDY:US 41.62B 965M
Eli Lilly And LLY:US $ 5650.3M 202.4M
Endo International Ordinary Shares ENDP:US $ 535.24M 94.12M
GlaxoSmithKline GSK:LN 5.72B 1.95B
Glaxosmithkline GSK:US 5.72B 1.95B
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Horizon Pharma HZNP:US $ 502.42M 2.82M
JAZZ PHA JAZZ:US $ 445.46M 46.64M
Johnson & Johnson JNJ:US $ 16.65B 1.76B
Lannett LCI:US $ 109.52M 241M
Merk MRK:US $ 9038M 5726M
Novartis NOVN:VX 10.28B 107M
Pacira Pharmaceuticals PCRX:US $ 99.59M 12.6M
Perrigo Ordinary Shares PRGO:US $ 958.6M 383.1M
Pfizer PFE:US $ 9065M 2442M
Phibro Animal Health PAHC:US $ 191.6M 5.34M
Supernus Pharmaceuticals SUPN:US $ 117.72M 17.16M
Teva Pharmaceutical TEVA:IT 3.55B 500M
Valeant Pharmaceuticals VRX:CN C$ 2.25B 27M
Zoetis ZTS:US $ 1.18B 203M